Skip to main content
logo
Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,010.00
+160.00 (2.74%)
Aug 12, 2026, 3:30 PM KST

Tdspharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
5,0554,2753,7184,6883,4562,063
Depreciation & Amortization
708.99699.57668.591,0221,2661,230
Loss (Gain) From Sale of Assets
-517.52-517.5288.76-0.2-6.24-11.14
Asset Writedown & Restructuring Costs
----52.24-
Provision & Write-off of Bad Debts
39.6841.0567.36-3.058.06-
Other Operating Activities
-1.99-632.63-187.02363.21-24.36361.45
Change in Accounts Receivable
-863.1-1,3031,329-975.88-2,596220.31
Change in Inventory
-529.42526.73-658.37-330.23-268.36-199.46
Change in Accounts Payable
977.02722.39-727.3546.36971.97-53.58
Change in Other Net Operating Assets
76.46-31.27-369.83-1,51682.5768.92
Operating Cash Flow
4,9453,7803,9293,2942,9423,680
Operating Cash Flow Growth
81.34%-3.79%19.29%11.94%-20.04%66.36%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13,243-12,884-715.7-213.82-625.42-200.89
Sale of Property, Plant & Equipment
424.83424.831.110.222.7323.64
Sale (Purchase) of Intangibles
---1.74-57.55-5.5-
Sale (Purchase) of Real Estate
564564----
Investment in Securities
-2,0786,946-12,500-4,527-515.58-1,478
Other Investing Activities
47.2-2,988-14.5728.39-93.9115.55
Investing Cash Flow
-14,349-8,003-13,311-4,770-1,218-1,640

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,594----
Long-Term Debt Issued
---300675-
Total Debt Issued
7,8001,594-300675-
Short-Term Debt Repaid
-----1,000-
Long-Term Debt Repaid
--863.17-320.63-124.81-85.06-51.2
Total Debt Repaid
-546.58-863.17-320.63-124.81-1,085-51.2
Net Debt Issued (Repaid)
7,253730.82-320.63175.19-410.06-51.2
Issuance of Common Stock
--13,390---
Repurchase of Common Stock
------2,706
Other Financing Activities
---619.33-0--
Financing Cash Flow
7,253730.8212,450175.19-410.06-2,757

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.040.020.02-0.21-0.04-
Net Cash Flow
-2,151-3,4923,068-1,3011,315-717.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8,298-9,1043,2133,0802,3173,479
Free Cash Flow Growth
--4.34%32.92%-33.40%75.45%
Free Cash Flow Margin
-27.29%-32.96%11.68%10.25%9.05%17.55%
Free Cash Flow Per Share
-1570.61-1721.47694.06723.32543.7937650.19
Levered Free Cash Flow
-10,001-10,7432,3962,4281,0522,720
Unlevered Free Cash Flow
-9,845-10,6042,5632,6171,1902,801

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
246.44223.46262.18280.43195.0984.97
Cash Income Tax Paid
1,0891,419572.49679.93561.14150.9
Change in Working Capital
-339.04-84.98-426.39-2,776-1,80936.18